Clinical study of Bilwadi Ghana Vati in the Management of Sthaulya in children

Efficacy of Bilwadi Ghana Vati in the management of Sthaulya w.s.r. to overweight children - An open labeled randomized control clinical trial - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/087109

Enrollment

100

Registered

2025-05-20

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E663- Overweight

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children having BMI more than 85th percentile and less than 95th percentile of CDC growth chart. 2. Minimum three classical signs and symptoms of Sthaulya viz. Chala Sphika Udara Stana, Aalasya/Utsah Hani, Kshudra Shwasa/Aayase Shwasa, Nidraadhikya, Swedaadhikya, Daurgandhya, Atipipasa, Atikshudha (Due to exogenous causes) 3. Children on oral medication for overweight (those who are willing to get enrolled) will be included in the study after a wash out period of one week.

Exclusion criteria

Exclusion criteria: 1. Children aged less than 5 years and more than 16 years. 2. Children who are known cases of any systemic, endocrinal illness like DM, Thyroid disorders, HTN, CHD, Asthma, etc. or known cases of any psychiatric or genetic disorders. 3. Children who are known case of drug induced overweight.

Design outcomes

Primary

Measure	Time frame
Change in BMI.Timepoint: Between 85th to 91st Day	—

Secondary

Measure	Time frame
Change in S. Adiponectine level.Timepoint: Between 85th to 91st Day	—

Countries

India

Contacts

Public ContactAnandkumar M Patel

Institute of Teaching and Research in Ayurveda

drvkkori@yahoo.co.in9409207285

Outcome results